MDCX logo

MDCX Medicus Pharma Ltd. Common Stock

NASDAQ Capital Market · Biotechnology · Healthcare

$1.69
-0.26 (-13.33%)

Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.

Market Cap: $2.42Mmedicuspharma.com

Price

No data yet.

Social Signal Score

45
5d
—
30d
50
2 mentions
—
60d
43
5 mentions
—
90d
43
10 mentions
—
news: 10

Analyst Ratings

2 analysts
Buyconsensus
Strong Buy 0Buy 2Hold 0Sell 0Strong Sell 0
Avg price target$1-40.8%
Low $1Median $1High $1
Current Consensus

Revenue

$0.00
$0.00
Jun 2023Sep 2026

Analyst Estimates

FY2025
$-90.75
$-90.75–$-90.75
1 analysts
FY2026
$-33.95
$-33.95–$-33.95
1 analysts
FY2027
$-15.15
$-15.15–$-15.15
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Raza Bokhari
Sector
Healthcare
Industry
Biotechnology
Employees
16
Beta
-0.61
Country
CA
Piotroski score
1 / 9 (Weak)
Altman Z-score
-17.46
medicuspharma.com